top of page
Clinically Proven — Integra Mozaik Osteoconductive
Scaffold has been shown to be equally effective to autograft

 A key clinical study on the use of the Integra Mozaik matrix (versus autograft) in posterolateral lumbar fusion supports the product’s safety and effectiveness as an alternative to autograft.
 

      

INTEGRA MOZAIK 
OSTEOCONDUCTIVE SCAFFOLD

  • Equivalent performance between the Integra Mozaik scaffold and autograft
     
  • Success in a patient population containing many common confounding factors or comorbidities including smoking, diabetes, and osteoporosis
     
  • In cases of successful fusion, definitive, uninterrupted bridging of well mineralized trabecular bone was observed 12 months after surgery, as determined by an independent radiologist blinded to treatment
     
  • Integra Mozaik scaffold applied as indicated with bone marrow aspirate alone, no addition of autograft or allograft
     
  • Spinal fusion comparisons performed in each patient individually, Integra Mozaik scaffold applied to the symptomatic side and autograft to the contralateral side
     
        

Representative radiographs from the referenced study. CT-scans from two patients at 12 months post-op.

                                  
Available sizes

Fusion rates were equivalent to autograft, including the ability to achieve fusion in 100% of one and two level procedures.

Single Level


Two Level


Three Level


Four Level
 

Synthetic Grafts

Clinical Performance

Mozaik Brochure

bottom of page